1018699-74-5 Usage
Description
N-(2-nitrophenyl)-5-methoxytryptamine, also known as 5-Nitro-2-MeO-DALT or 5-Nitro-MeO-DALT, is a synthetic tryptamine derivative with psychoactive properties. It is a psychedelic substance that can induce hallucinogenic effects, alter perception, and produce changes in mood and cognition.
Uses
Used in Research Applications:
N-(2-nitrophenyl)-5-methoxytryptamine is used as a research chemical for studying the effects of psychoactive substances on the human brain and nervous system. Its structural similarity to other tryptamines allows researchers to investigate the mechanisms of action and potential therapeutic applications of these compounds.
Used in Controlled Substances Regulation:
Due to its potential for abuse and adverse health effects, N-(2-nitrophenyl)-5-methoxytryptamine is considered a controlled substance in many countries. It is used as a reference point for regulatory agencies to develop policies and guidelines for the control and monitoring of psychoactive substances.
Check Digit Verification of cas no
The CAS Registry Mumber 1018699-74-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,8,6,9 and 9 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1018699-74:
(9*1)+(8*0)+(7*1)+(6*8)+(5*6)+(4*9)+(3*9)+(2*7)+(1*4)=175
175 % 10 = 5
So 1018699-74-5 is a valid CAS Registry Number.
1018699-74-5Relevant articles and documents
Substituted Aryl-Indole Compounds and Their Kynurenine/Kynuramine-Like Metabolites As Therapeutic Agents
-
Page/Page column 7, (2008/12/05)
This invention is directed to substituted aryl compounds, which are linked to a substituted indole moiety by various linkers, and the kynurenine/kynuramine-like metabolites of these agents, their preparation and pharmaceutical compositions containing these compounds. This invention further is directed to the pharmaceutical use of the compounds for inhibiting GSK3β kinase and/or modulating N-methyl-D-aspartate (NMDA) channel activities for the treatment of neurodegenerative and other disorders.
